Xiaohong Hou

Zunyi, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Heterogeneity of immune checkpoint inhibitor-related inflammatory central nervous system adverse event reporting signals in primary and metastatic brain tumors: a pharmacovigilance study with single-cell and spatial transcriptomic contextualization.

Heterogeneity of immune checkpoint inhibitor-related inflammatory central nervous system adverse event reporting signals in primary and metastatic brain tumors: a pharmacovigilance study with single-cell and spatial transcriptomic contextualization.

Journal: Frontiers in immunology

Published: April 27, 2026

GALNT6-mediated O-glycosylation on PTGS2 regulates microglia inflammation and ferroptosis following intracerebral hemorrhage.

GALNT6-mediated O-glycosylation on PTGS2 regulates microglia inflammation and ferroptosis following intracerebral hemorrhage.

Journal: International immunopharmacology

Published: March 12, 2026

A multi-database pharmacovigilance study reveals distinctive immunosuppressive and opportunistic infection disproportionality signals with bevacizumab and temozolomide combination therapy in glioblastoma.

A multi-database pharmacovigilance study reveals distinctive immunosuppressive and opportunistic infection disproportionality signals with bevacizumab and temozolomide combination therapy in glioblastoma.

Journal: Frontiers in medicine

Published: December 22, 2025

Venous Thromboembolism and Bleeding with Temozolomide-, Bevacizumab-, and Nitrosourea-Based Therapy in Glioma: A Dual-Database Pharmacovigilance Study.

Venous Thromboembolism and Bleeding with Temozolomide-, Bevacizumab-, and Nitrosourea-Based Therapy in Glioma: A Dual-Database Pharmacovigilance Study.

Journal: Cancers

Published: December 02, 2025

WTAP-mediated N6-methyladenosine modification of UQCRQ promotes mitochondrial ROS and inflammatory response in microglia after intracerebral hemorrhage.

WTAP-mediated N6-methyladenosine modification of UQCRQ promotes mitochondrial ROS and inflammatory response in microglia after intracerebral hemorrhage.

Journal: Biochemical and biophysical research communications

Published: October 17, 2025

ANG peptide-modified exosomes loaded with oleanolic acid target GPX4 for enhanced breast cancer brain metastasis therapy.

ANG peptide-modified exosomes loaded with oleanolic acid target GPX4 for enhanced breast cancer brain metastasis therapy.

Journal: Journal of neuro-oncology

Published: September 04, 2025

CD2-CD58 axis orchestrates cytotoxic T lymphocyte function and metabolic crosstalk in breast cancer brain metastasis.

CD2-CD58 axis orchestrates cytotoxic T lymphocyte function and metabolic crosstalk in breast cancer brain metastasis.

Journal: Journal of cell communication and signaling

Published: June 11, 2025

Increased CCL18 expression infers a poor prognosis in glioblastoma multiforme and promotes U-87 MG cell proliferation and migration: A retrospective cohort study.

Increased CCL18 expression infers a poor prognosis in glioblastoma multiforme and promotes U-87 MG cell proliferation and migration: A retrospective cohort study.

Journal: Medicine

Published: May 29, 2025

Identification of a novel glioblastoma multiforme molecular subtype with poor prognosis and high immune infiltration based on oxidative stress-related genes.

Identification of a novel glioblastoma multiforme molecular subtype with poor prognosis and high immune infiltration based on oxidative stress-related genes.

Journal: Medicine

Published: February 16, 2024

Interaction network of immune-associated genes affecting the prognosis of patients with glioblastoma.

Interaction network of immune-associated genes affecting the prognosis of patients with glioblastoma.

Journal: Experimental and therapeutic medicine

Published: October 15, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026